Clinical Trials Browser

Phase 1 × INDUSTRY × Breast Cancer Lymphedema × Clear all

NCT02994771 2023-04-24

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Phase 1 Terminated

Breast Cancer Lymphedema